Changes in Insulin: Glucose, Glucagon: Glucose, and Insulin: Glucagon Ratios Correlate with Glycemic Response in Patients with Type 2 Diabetes Treated with Saxagliptin Plus Dapagliflozin Add-on to Metformin Therapy

被引：0
|
作者：
Hansen, Lars
Iqbal, Nayyar
Elkholm, Ella
Chen, Hungta
Cook, William
Hirshberg, Boaz
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1212-P
引用
收藏
页码：A313 / A313
页数：1
相关论文
共 50 条
  • [21] SOLUTION study: Effect of gemigliptin as add-on therapy to dapagliflozin plus metformin in patients with type 2 diabetes
    Lee, B. W.
    Min, K. W.
    Hong, E. G.
    Ku, B. J.
    Kang, J. G.
    Chon, S.
    Kim, J. H.
    Park, M. K.
    Lee, W. Y.
    Kim, S. Y.
    Song, K. H.
    Yoo, S. J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [22] INSULIN AND GLUCAGON RESPONSE TO GLUCOSE AND ARGININE IN 2 PATIENTS WITH AUTOIMMUNE DIABETES-MELLITUS
    DELPRETE, GF
    TIENGO, A
    BERSANI, G
    NOSADINI, R
    GAROTTI, C
    TRISOTTO, A
    HORMONE AND METABOLIC RESEARCH, 1976, 8 (02) : 149 - 150
  • [23] Real-World Use of Dapagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Spaic, Tamara
    Harris, Stewart B.
    Mequanint, Selam
    Reichert, Sonja
    Miller, Kristina
    DIABETES, 2017, 66 : A327 - A328
  • [24] Add-On Treatment with Teneligliptin Ameliorates Glucose Fluctuations and Improves Glycemic Control Index in Japanese Patients with Type 2 Diabetes on Insulin Therapy
    Tanaka, Seiichi
    Suzuki, Kunihiro
    Aoki, Chie
    Niitani, Mai
    Kato, Kanako
    Tomotsune, Takanori
    Aso, Yoshimasa
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (12) : 840 - 845
  • [25] Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy
    Anthony H. Barnett
    Bernard Charbonnel
    Jia Li
    Mark Donovan
    Douglas Fleming
    Nayyar Iqbal
    Clinical Drug Investigation, 2013, 33 : 707 - 717
  • [26] Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy
    Barnett, A. H.
    Charbonnel, B.
    Li, J.
    Donovan, M.
    Fleming, D.
    DIABETOLOGIA, 2011, 54 : S108 - S109
  • [27] Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian Emil
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Hansen, Lars
    Iqbal, Nayyar
    DIABETES CARE, 2015, 38 (11) : 2009 - 2017
  • [28] Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy
    Barnett, Anthony H.
    Charbonnel, Bernard
    Li, Jia
    Donovan, Mark
    Fleming, Douglas
    Iqbal, Nayyar
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 707 - 717
  • [29] Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
    Rosenstock, Julio
    Hansen, Lars
    Zee, Pamela
    Li, Yan
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    DIABETES CARE, 2015, 38 (03) : 376 - 383
  • [30] A Randomized, Double-Blind, Phase 3 Trial of Dapagliflozin Add-on to Saxagliptin plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian E.
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Hansen, Lars
    Iqbal, Nayyar
    DIABETES, 2015, 64 : A28 - A28
12345